{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:40:32Z","timestamp":1790214032958,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0446"],"award-info":[{"award-number":["W81XWH-20-1-0446"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-1-0545"],"award-info":[{"award-number":["W81XWH-15-1-0545"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007623","name":"School of Medicine, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.nbd.2022.105699","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T13:42:05Z","timestamp":1647610925000},"page":"105699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia"],"prefix":"10.1016","volume":"168","author":[{"given":"Anthony M.","family":"Downs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Donsante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Jinnah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2022.105699_bb0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cne.1186","article-title":"Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways","volume":"434","author":"Alcantara","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2022.105699_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/01.WNL.0000149764.34953.BF","article-title":"Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation","volume":"64","author":"Asanuma","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2022.105699_bb0015","first-page":"53","article-title":"Dopamine transmission in DYT1 dystonia","volume":"94","author":"Augood","year":"2004","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2022.105699_bb0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1471-4159.2007.04590.x","article-title":"Dopamine release is impaired in a mouse model of DYT1 dystonia","volume":"102","author":"Balcioglu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2022.105699_bb0025","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1093\/brain\/awt282","article-title":"Striatal dopaminergic dysfunction at rest and during task performance in writer\u2019s cramp","volume":"136","author":"Berman","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2022.105699_bb0030","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(25)11335-9","article-title":"Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells","volume":"260","author":"Bolden","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2022.105699_bb0035","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1523\/JNEUROSCI.08-12-04646.1988","article-title":"Localization of a family of muscarinic receptor mRNAs in rat brain","volume":"8","author":"Buckley","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.36.2.160","article-title":"Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl","volume":"36","author":"Burke","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2022.105699_bb0045","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1460-9568.2003.02588.x","article-title":"Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity","volume":"17","author":"Bymaster","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0050","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/WNL.0b013e3181aa538f","article-title":"Abnormal striatal and thalamic dopamine neurotransmission: genotype-related features of dystonia","volume":"72","author":"Carbon","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2022.105699_bb0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-3565(25)23208-6","article-title":"Antagonist binding profiles of five cloned human muscarinic receptor subtypes","volume":"256","author":"Dorje","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2022.105699_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2019.01.012","article-title":"Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia","volume":"125","author":"Downs","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2022.105699_bb0065","first-page":"S283","article-title":"Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission","volume":"153","author":"Exley","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2022.105699_bb0070","first-page":"177","article-title":"High-dosage anticholinergic therapy in dystonia","volume":"37","author":"Fahn","year":"1983","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2022.105699_bb0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/jpet.117.246348","article-title":"Dopamine receptor agonist treatment of idiopathic dystonia: a reappraisal in humans and mice","volume":"365","author":"Fan","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2022.105699_bb0080","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1523\/JNEUROSCI.4896-13.2014","article-title":"M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor\u2019s location","volume":"34","author":"Foster","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0085","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","article-title":"Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release","volume":"91","author":"Foster","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2022.105699_bb0090","doi-asserted-by":"crossref","first-page":"15312","DOI":"10.1073\/pnas.261583798","article-title":"Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice","volume":"98","author":"Gerber","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2022.105699_bb0095","doi-asserted-by":"crossref","first-page":"15312","DOI":"10.1073\/pnas.261583798","article-title":"Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice","volume":"98","author":"Gerber","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2022.105699_bb0100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuron.2005.11.010","article-title":"Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope","volume":"48","author":"Goodchild","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2022.105699_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nbd.2012.03.024","article-title":"Generation of a novel rodent model for DYT1 dystonia","volume":"47","author":"Grundmann","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105699_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004714-200002000-00013","article-title":"Comparison of central and peripheral pharmacologic effects of biperiden and trihexyphenidyl in human volunteers","volume":"20","author":"Guthrie","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.nbd.2022.105699_bb0115","first-page":"323","article-title":"Expression of m1 and m4 muscarinic receptor mRNA in the striatum following a selective lesion of striatonigral neurons","volume":"734","author":"Harrison","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2022.105699_bb0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2014.09.028","article-title":"Modulation of direct pathway striatal projection neurons by muscarinic M(4)-type receptors","volume":"89","author":"Hernandez-Flores","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2022.105699_bb0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nn.4332","article-title":"The mouse cortico-striatal projectome","volume":"19","author":"Hintiryan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0130","first-page":"195","article-title":"Molecular genetics of DOPA-responsive dystonia","volume":"80","author":"Ichinose","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2022.105699_bb0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mds.870040302","article-title":"Treatment of movement disorders with trihexyphenidyl","volume":"4","author":"Jabbari","year":"1989","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2022.105699_bb0140","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1523\/JNEUROSCI.3843-09.2010","article-title":"A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors","volume":"30","author":"Jeon","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0145","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1073\/pnas.0912540107","article-title":"Presynaptic m1 muscarinic receptors are necessary for mGluR long-term depression in the hippocampus","volume":"107","author":"Kamsler","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2022.105699_bb0150","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","article-title":"Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies","volume":"11","author":"Levey","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0155","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejpn.2016.02.003","article-title":"Medication use in childhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.nbd.2022.105699_bb0160","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/mds.26009","article-title":"Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors","volume":"29","author":"Maltese","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2022.105699_bb0165","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/brain\/awp194","article-title":"Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine","volume":"132","author":"Martella","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2022.105699_bb0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nbd.2014.01.016","article-title":"Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia","volume":"65","author":"Martella","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105699_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ncl.2014.09.011","article-title":"Drug-induced movement disorders","volume":"33","author":"Mehta","year":"2015","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.nbd.2022.105699_bb0180","series-title":"Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with \u201cIn Vivo\u201d Anti-Parkinsonian and Anti-Dystonic Efficacy","author":"Moehle","year":"2020"},{"key":"10.1016\/j.nbd.2022.105699_bb0185","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1523\/JNEUROSCI.0730-15.2015","article-title":"Sensing positive versus negative reward signals through adenylyl cyclase-coupled GPCRs in direct and indirect pathway striatal medium spiny neurons","volume":"35","author":"Nair","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuropharm.2018.11.029","article-title":"The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia","volume":"146","author":"Nair","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2022.105699_bb0195","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/brain\/awu022","article-title":"Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood","volume":"137","author":"Ng","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2022.105699_bb0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng0997-40","article-title":"The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein","volume":"17","author":"Ozelius","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2022.105699_bb0205","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nbd.2010.04.016","article-title":"Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice","volume":"39","author":"Page","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105699_bb0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1021\/cn500003z","article-title":"M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses","volume":"5","author":"Pancani","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0215","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nbd.2006.07.006","article-title":"Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia","volume":"24","author":"Pisani","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105699_bb0220","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa1207281","article-title":"Brain dopamine-serotonin vesicular transport disease and its treatment","volume":"368","author":"Rilstone","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2022.105699_bb0225","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/brain\/awv212","article-title":"A new knock-in mouse model of l-DOPA-responsive dystonia","volume":"138","author":"Rose","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2022.105699_bb0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2017.06.005","article-title":"Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia","volume":"295","author":"Scarduzio","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2022.105699_bb0235","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ncl.2009.04.010","article-title":"Genetics and treatment of dystonia","volume":"27","author":"Schwarz","year":"2009","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.nbd.2022.105699_bb0240","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1523\/JNEUROSCI.0041-12.2012","article-title":"Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia","volume":"32","author":"Sciamanna","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2012.05.009","article-title":"Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia","volume":"48","author":"Song","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105699_bb0250","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.brainresrev.2007.10.008","article-title":"Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons","volume":"58","author":"Tepper","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2022.105699_bb0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13311-013-0231-4","article-title":"Treatment of dystonia","volume":"11","author":"Thenganatt","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2022.105699_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnsys.2011.00011","article-title":"Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons","volume":"5","author":"Threlfell","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0265","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","article-title":"Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum","volume":"30","author":"Threlfell","year":"2010","journal-title":"J. Neurosci."},{"issue":"Suppl. 7","key":"10.1016\/j.nbd.2022.105699_bb0270","article-title":"Dystonia in Parkinson\u2019s disease","volume":"253","author":"Tolosa","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2022.105699_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.lfs.2003.09.022","article-title":"Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology","volume":"74","author":"Yamada","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2022.105699_bb0280","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jneumeth.2011.03.001","article-title":"Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures","volume":"202","author":"Yorgason","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2022.105699_bb0285","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","article-title":"Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0290","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1523\/JNEUROSCI.22-05-01709.2002","article-title":"Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105699_bb0295","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/mol.109.056317","article-title":"Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum","volume":"76","author":"Zhang","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2022.105699_bb0300","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1523\/JNEUROSCI.0261-09.2009","article-title":"Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine","volume":"29","author":"Zhang","year":"2009","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:01:09Z","timestamp":1778792469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996122000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":60,"alternative-id":["S0969996122000912"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105699","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.17.423273","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105699"}}